Literature DB >> 10828023

Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes.

S S El-Daher1, Y Patel, A Siddiqua, S Hassock, S Edmunds, B Maddison, G Patel, D Goulding, F Lupu, R J Wojcikiewicz, K S Authi.   

Abstract

Platelet activation is associated with an increase of cytosolic Ca(++) levels. The (1,4,5)IP(3) receptors [(1,4,5)IP(3)R] are known to mediate Ca(++) release from intracellular stores of many cell types. Currently there are at least 3 distinct subtypes of (1,4, 5)IP(3)R-type I, type II, and type III-with suggestions of distinct roles in Ca(++) elevation. Specific receptors for (1,3,4,5)IP(4) belonging to the GAP1 family have also been described though their involvement with Ca(++) regulation is controversial. In this study we report that platelets contain all 3 subtypes of (1,4,5)IP(3)R but in different amounts. Type I and type II receptors are predominant. In studies using highly purified platelet plasma (PM) and intracellular membranes (IM) we report a distinct localization of these receptors. The PM fractions were found to contain the type III (1,4,5)IP(3)R and GAP1(IP4BP) in contrast to IM, which contained type I (1,4,5)IP(3)R. The type II receptor exhibited a dual distribution. In studies examining the labeling of surface proteins with biotin in intact platelets only the type III (1,4,5)IP(3)R was significantly labeled. Immunogold studies of ultracryosections of human platelets showed significantly more labeling of the PM with the type III receptor antibodies than with type I receptor antibodies. Ca(++) flux studies were carried out with the PM to demonstrate in vitro function of inositol phosphate receptors. Ca(++) release activities were present with both (1,4,5)IP(3) and (1, 3,4,5)IP(4) (EC(50) = 1.3 and 0.8 micromol/L, respectively). Discrimination of the Ca(++)-releasing activities was demonstrated with cyclic adenosine monophosphate (cAMP)-dependent protein kinase (cAMP-PK) specifically inhibiting (1,4,5)IP(3) but not (1,3,4, 5)IP(4)-induced Ca(++) flux. In experiments with both PM and intact platelets, the (1,4,5)IP(3)Rs but not GAP1(IP4BP) were found to be substrates of cAMP-PK and cGMP-PK. Thus the Ca(++) flux property of (1,3,4,5)IP(4) is insensitive to cAMP-PK. These studies suggest distinct roles for the (1,4,5)IP(3)R subtypes in Ca(++) movements, with the type III receptor and GAP1(IP4BP) associated with cation entry in human platelets and the type I receptor involved with Ca(++) release from intracellular stores.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828023

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Coupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depleted.

Authors:  J A Rosado; S O Sage
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

2.  RASA3 is a critical inhibitor of RAP1-dependent platelet activation.

Authors:  Lucia Stefanini; David S Paul; Raymond F Robledo; E Ricky Chan; Todd M Getz; Robert A Campbell; Daniel O Kechele; Caterina Casari; Raymond Piatt; Kathleen M Caron; Nigel Mackman; Andrew S Weyrich; Matthew C Parrott; Yacine Boulaftali; Mark D Adams; Luanne L Peters; Wolfgang Bergmeier
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

3.  Activation of store-mediated calcium entry by secretion-like coupling between the inositol 1,4,5-trisphosphate receptor type II and human transient receptor potential (hTrp1) channels in human platelets.

Authors:  J A Rosado; S O Sage
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

4.  The relative role of PLCbeta and PI3Kgamma in platelet activation.

Authors:  Lurong Lian; Yanfeng Wang; Julia Draznin; Don Eslin; Joel S Bennett; Mortimer Poncz; Dianqing Wu; Charles S Abrams
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

5.  Headpiece domain of dematin regulates calcium mobilization and signaling in platelets.

Authors:  Adam J Wieschhaus; Guy C Le Breton; Athar H Chishti
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

6.  An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice.

Authors:  Johannes Grosse; Attila Braun; David Varga-Szabo; Niklas Beyersdorf; Boris Schneider; Lutz Zeitlmann; Petra Hanke; Patricia Schropp; Silke Mühlstedt; Carolin Zorn; Michael Huber; Carolin Schmittwolf; Wolfgang Jagla; Philipp Yu; Thomas Kerkau; Harald Schulze; Michael Nehls; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  An inositol 1,4,5-trisphosphate receptor-dependent cation entry pathway in DT40 B lymphocytes.

Authors:  Guillermo Vazquez; Barbara J Wedel; Gary St J Bird; Suresh K Joseph; James W Putney
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

8.  Rapid agonist-evoked coupling of type II Ins(1,4,5)P3 receptor with human transient receptor potential (hTRPC1) channels in human platelets.

Authors:  Sharon L Brownlow; Stewart O Sage
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 9.  Proteomics: A Tool to Study Platelet Function.

Authors:  Olga Shevchuk; Antonija Jurak Begonja; Stepan Gambaryan; Matthias Totzeck; Tienush Rassaf; Tobias B Huber; Andreas Greinacher; Thomas Renne; Albert Sickmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 10.  Ca(2+) channels on the move.

Authors:  Colin W Taylor; David L Prole; Taufiq Rahman
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.